# MDxHealth (MDXH) — Earnings

MDXH · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mdxh/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.18 |
| EPS estimate | −$0.19 |
| EPS surprise | +6.93% |
| Revenue surprise | +4.07% |
| Revenue | $27.2M |
| Revenue estimate | $26.1M |
| Reported | Aug 13, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1872529/000121390026089082/ea0301894-6k_mdxhealth.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/5b3142d1-6007-09a4-8bd1-b57cfa8af0f3.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 13, 2026 | −$0.19 | −$0.18 | 6.93% | $26.1M | $27.2M |
| Q1 2026 | May 13, 2026 | −$0.14 | −$0.19 | -31.31% | $30.9M | $23.9M |
| Q4 2025 | Feb 26, 2026 | −$0.13 | −$0.17 | -35.46% | $30.4M | $29.5M |
| Q3 2025 | Nov 12, 2025 | −$0.11 | −$0.16 | -49.67% | $28.1M | $27.4M |
| Q2 2025 | Aug 5, 2025 | −$0.12 | −$0.15 | -21.65% | $26.3M | $26.6M |
| Q1 2025 | May 14, 2025 | −$0.13 | −$0.19 | -46.15% | $23.9M | $24.3M |
| Q4 2024 | Feb 26, 2025 | −$0.19 | −$0.14 | 27.08% | $23.3M | $24.7M |
| Q3 2024 | Nov 6, 2024 | −$0.27 | −$0.40 | -48.20% | $21.5M | $23.3M |
| Q2 2024 | Aug 21, 2024 | −$0.27 | −$0.42 | -52.89% | $20.9M | $22.2M |
| Q1 2024 | May 1, 2024 | −$0.30 | −$0.31 | -3.61% | $18.1M | $19.8M |
| Q4 2023 | Mar 6, 2024 | −$0.21 | −$0.39 | -84.75% | $18.6M | $19.4M |
| Q3 2023 | Nov 8, 2023 | −$0.30 | −$0.40 | -33.29% | $18.2M | $19.4M |
| Q2 2023 | Aug 23, 2023 | −$0.33 | −$0.40 | -20.85% | $15.2M | $16.7M |
| Q1 2023 | May 15, 2023 | −$0.41 | −$0.50 | -21.01% | $13.6M | $14.7M |

## Frequently Asked Questions

### When did MDxHealth (MDXH) last report earnings?

MDxHealth last reported on Aug 13, 2026, covering fiscal Q2 2026.

### Did MDXH beat earnings estimates?

Yes. MDxHealth reported EPS of −$0.18 for Q2 2026 against a −$0.19 estimate — a 6.93% beat.

### How much revenue did MDXH report last quarter?

MDxHealth reported $27.2M in revenue for Q2 2026, against a consensus estimate of $26.1M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).